N

Neurocrine Biosciences

Develops and markets neurology-focused therapies

Medical Director Immunology

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSan Diego, CA, USAIn-person

About the Job

Requirements

  • An MD or DO degree, accredited residency training, and board certification in a clinical specialty relevant to the therapeutic area are required.
  • At least 2 years of experience in clinical research and development (Phase 1–4) in a pharmaceutical or biotechnology company, clinical research or academic environment, or related experience is required.

Responsibilities

  • Lead the design, development, and execution of Phase 1–3 clinical studies in collaboration with multidisciplinary development teams.
  • Develop and implement clinical study protocols and contribute to clinical research strategy for assigned programs.
  • Serve as a Sponsor Medical Monitor, providing medical oversight during study conduct and making study-level medical and safety decisions.
  • Partner with Drug Safety colleagues to assess adverse events, evaluate emerging safety information, and support benefit-risk assessments.
  • Work with Clinical Operations to oversee study execution in accordance with Good Clinical Practice, applicable regulations, and company procedures.
  • Analyze and interpret clinical data and translate findings into scientific and development insights.
  • Contribute to clinical study reports, investigator brochures, regulatory documents, and materials supporting clinical development and regulatory interactions.
  • Partner with Clinical Pharmacology, Biometrics, Translational Medicine, and Research colleagues to incorporate biomarkers and translational endpoints into development plans where appropriate.
  • Identify and engage clinical investigators, consultants, and external experts, and build relationships with leaders in the Immunology community.
  • Apply knowledge of the evolving treatment landscape, standards of care, competitor activity, and emerging science to study-level development decisions.
  • Collaborate across Research, Product Development, Business Development, Medical Affairs, and other functions to evaluate development opportunities and inform clinical research plans.
  • Communicate study progress, emerging data, risks, and recommendations to development teams and senior leaders.

Desired Qualifications

  • Clinical expertise in gastroenterology, dermatology, or another specialty relevant to immune-mediated disease.
  • Experience serving as a Medical Monitor and/or Study Lead for industry-sponsored clinical trials.
  • Experience designing clinical studies and developing protocols, including selecting endpoints, eligibility criteria, dose strategy, and other key design elements.
  • Experience in early clinical development, including translating preclinical or translational findings into clinical hypotheses and development plans.
  • Experience working on Phase 2 or Phase 3 studies in immune-mediated diseases.
  • Experience interpreting emerging efficacy, safety, biomarker, and pharmacology data to inform study-level decisions.
  • Working knowledge of global drug-development requirements, Good Clinical Practice, and regulatory expectations for investigational therapies.
  • Experience contributing to regulatory documents and interacting with health authorities.
  • Experience engaging investigators, key external experts, contract research organizations, and other external partners.
  • Strong understanding of the competitive and evolving treatment landscape within gastroenterology, dermatology, or Immunology more broadly.
  • Ability to influence and lead cross-functional teams without relying on direct reporting authority.

About the Company

Neurocrine Biosciences

Develops and markets neurology-focused therapies

Neurocrine Biosciences develops and commercializes medicines for neurological and endocrine diseases. Its work centers on discovering and developing treatments, with INGREZZA (valbenazine) approved to treat adults with tardive dyskinesia and a pipeline of other drug candidates in various clinical stages. The company earns revenue from sales of approved medicines and from milestones and royalties from collaborations with partners. By focusing on both neurological and endocrine conditions, Neurocrine targets patients and healthcare professionals seeking therapies for conditions such as tardive dyskinesia, Parkinson's disease, and endometriosis. Its main goal is to bring therapies to market through development and commercialization, supported by ongoing research across its clinical programs to address unmet medical needs in these areas.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Diego, CA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Neurocrine Biosciences

See more jobs